The objective of this study was to determine the relationship of serum vitamin D defi ciency (VDD) to histologic features of non-alcoholic fatty liver disease (NAFLD), and associated demographic, clinical, laboratory, and transcriptomic data in the well-characterized Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN) cohort.
INTRODUCTION
Vitamin D, specifi cally the biologically active vitamin D metabolite 1,25-dihydroxyvitamin D (calcitriol: 1,25(OH)2D), is known to exert important physiological eff ects in addition to well-known eff ects on calcium metabolism. Vitamin D receptors (VDRs) are ubiquitously expressed in several tissues, including gut, liver, adipose tissues, cardiac and skeletal muscles, β -cells, and immune cells such as lymphocytes, dendritic cells, and monocytes/macrophages ( 1 ) . Vitamin D3 (VD3) is inversely associated with obesity and insulin resistance (IR), and there is increasing evidence that vitamin D defi ciency (VDD) may contribute to the development of diabetes mellitus, and the metabolic syndrome ( 2, 3 ) . VDD may also have a potential role in autoimmune and infl ammatory processes through production of proinfl ammatory cytokines (2) (3) (4) . VDD continues to be largely undertreated in children and adults worldwide ( 4 ) . Recently, in adolescents in the United States, 14-55% were reported to be vitamin D defi cient with 25-hydroxy vitamin D (25(OH)D) concentrations <20 ng/ml ( 5, 6 ) . In the United States, obese Black Americans are at particularly high risk for VDD; higher rates of VDD, obesity, and type 2 diabetes mellitus were found in African Americans as compared with Caucasians ( 7, 8 ) . Recent studies of VDD in humans and animal models indicate that VDD also contributes to increased oxidative stress, systemic infl ammation, decreased adiponectin levels, toll-like receptor activation, and non-alcoholic fatty liver disease (NAFLD) ( 2, (9) (10) (11) (12) (13) .
NAFLD is the most common liver disease in developed countries, aff ecting one of every three adults ( 14 ) and about 10% of children ( 15 ) . NAFLD has emerged as a major risk factor for diabetes and cardiovascular disease, independent of obesity ( 16, 17 ) . Given the potential for NAFLD to progress to non-alcoholic steatohepatitis (NASH), the more severe form of the disease, with the risk of further progression to cirrhosis and hepatocellular cancer, it is imperative that metabolic risk factors and pathological mechanisms are identifi ed. VDD has emerged as a risk factor for NAFLD; several large epidemiologic studies using surrogate markers of NALFD, such as alanine aminotransferase (ALT) levels or abdominal imaging studies, suggest that VDD is prevalent among cases of suspected NAFLD compared with controls without evidence of liver disease (18) (19) (20) . However, this association failed to persist upon multivariate analysis controlling for covariates in some studies ( 19, 20 ) . A recent meta-analysis concluded that NAFLD patients have decreased 25(OH)D levels compared with controls ( 21 ) . VDD has also been associated with an increased likelihood of steatosis, fi brosis, and necroinfl ammation in both children and adults in biopsy-proven NAFLD ( 2, (22) (23) (24) (25) , but other studies have failed to fi nd an association ( 26, 27 ) . Two recent rat studies by our group ( 9 ) and Nakano et al. ( 28 ) showed that VDD leads to IR, increased infl ammation, and exacerbates the severity of NAFLD. Nakano et al. ( 28 ) also showed that phototherapy leading to increased VD levels can improve hepatocyte apoptosis, infl ammation, fi brosis, and IR. In our previous rodent study, we found activation of the nuclear factor-κ B (NF-κ B) pathway and increased hepatic expression of Toll-like receptor (TLR) genes TLR-2, -4, and -9 as well as resistin, hemeoxygenase, and interleukin-1β (IL-1β ), -4, and -6, suggesting that VDD may contribute to NASH pathogenesis through TLR activation and stimulation of a downstream infl ammatory response ( 9 ) .
Th e aim of this study was to determine the relationship of serum vitamin D levels to histologic features of NAFLD, and associated demographic, clinical, transcriptomic, and laboratory data in the well-characterized multicenter NASH Clinical Research Network (NASH CRN) cohort.
METHODS

Study population
Th is study was approved as an ancillary study of the NASH CRN. All subjects gave written informed consent and the study was approved by the institutional review board at each local site of the NASH CRN. Th e inclusion and exclusion criteria for patients enrolled in NASH CRN studies are published ( 29, 30 ) . For this study, a total of 190 NASH CRN adult subjects (age ≥18 years) with biopsy-proven NAFLD (defi ned as >5% steatosis) and available serum for evaluation of serum vitamin D levels. Subjects were randomly chosen to approximate equivalent representation of each clinical center, while maximizing the number of subjects with available transcriptomic and cytokine level data. Histological features of fatty liver disease were assessed by the pathology committee of NASH CRN in a centralized consensus review format using the criteria described previously ( 31 ) . Th e quality of liver biopsy specimens was similar to previous reports (29) (30) (31) . Subjects were categorized according to their level of serum vitamin D as either vitamin D suffi cient (vitamin D >30 ng/ml), vitamin D insuffi cient (vitamin D≥20≤30 ng/ml), or vitamin D defi cient (<20 ng/ml). Demographic information such as age, gender, ethni city, race, household income, and medical history to identify comorbidities and medications were obtained from patient interviews during screening. A physical exam including body weight and height measures was performed following the NASH CRN protocol ( 29, 30 ) . Laboratory data including hepatic, hematologic, metabolic, lipid, and serum iron assessments were analyzed for subjects with values collected within 6 months of the liver biopsy. Total dietary consumption of and supplementation of vitamin D and calcium were determined from the Block 98 food frequency questionnaire (NutritionQuest, Berkeley, CA); alcohol consumption was determined from the AUDIT-C questionnaires completed during study visits closest to the time of biopsy (available in 73% of subjects). Exercise habits were determined from a Physical Activity Questionnaire (available in 68% of subjects). Th e prevalence of the metabolic syndrome in this cohort was defi ned using the World Health Organization criteria.
Serologic data
Serum samples were collected in the morning following a 12 h fast and stored at −80 °C until use. Serum tumor necrosis factor-α , IL-6, IL-1β , IL-8, resistin, and adiponectin levels, determined using Luminex Technology and the Human Cytokine LINCOplex Kit (catalog number HCYTO-60K; Millipore, St Charles, MO), were available in 68%, 67%, 58%, 67%, 67%, and 66% of subjects, • SUNSHINE -average percentage of possible (percentage of the day which is daylight hours for that location during that month) • CLEAR DAYS -defi ned as 70% -100% sunshine; mean value of 85% was used.
• PARTLY CLOUDY DAYS -defi ned as 30%-60% sunshine; mean value of 45% was used.
• CLOUDY DAYS -defi ned as 0% -20% sunshine; mean value of 10% was used.
Determination of metabolic equivalents
Since physical activity (and socioeconomic status) have been defi ned as risk factors for VDD ( 33 ), we extrapolated data from the Physical Activity and Modifi ed Questionnaires used in the NASH CRN Database 1 and PIVENS Studies and convert to metabolic equivalents-minutes per week as described previously ( 34 ) .
RNA isolation and RNA sequencing library construction
RNA was isolated from fl ash frozen liver tissue using either the RNAqueous-Micro Kit (Life Technologies, Grand Island, NY) or the miRNeasy Kit (Qiagen, Germantown, MD) according to the manufacturer's protocol. Th e quality of the isolated RNAs was assessed using an Agilent Bioanalyzer (Santa Clara, CA) to determine an RNA integrity number (RIN) value. Only RNAs with RNA integrity number ≥7.0 were used for sequencing. RNA concentrations were determined using a NanoDrop ND-1000 spectrophotometer (Wilmington, DE). RNA-seq libraries were constructed from 100 ng of RNA using the TruSeq Stranded Total RNA Sample Prep Kit (Illumina, San Diego, CA), with ribosomal depletion. Libraries were clustered on a fl owcell using the TruSeq Paired-end Cluster Kit v.3 using a cBot clustering instrument (Illumina), followed by paired-end sequencing on a HiScanSQ (Illumina) for 50 cycles in either direction. Aft er the run was completed, the reads were demultiplexed and FASTQ fi les were generated using Illumina's Casava soft ware for each sample output. Read quality was analyzed by generating QC plots.
Sequence alignment and gene counts
Libraries were processed via a custom Galaxy workfl ow created for paired-end, stranded data (35) (36) (37) . Read alignment to Ensembl's GRCh37.66 gtf ( 38 ) was performed using TopHat v.1.4.1 ( 39 ) . Th e single-paired fl ag was set to "paired, " library type was set to "FR fi rst strand, " and mean inner distance between pairs was set to 170. All other TopHat parameters were set to defaults. HTSeq count was used to generate gene counts following conversion of BAM fi les into SAM fi les with mode set to "Intersection (nonempty), " stranded set to "Reverse, " minimum alignment quality set to 0, and all other set to default parameters ( 40 ) .
Normalization and differential expression
Th e R Bioconductor package edgeR was used to determine diff erential expression between VDD ( n =31) or not VDD (i.e., 25(OH) D3 levels ≥20 ng/ml; n =38) ( 41 ) . A standard edgeR workfl ow was used (i.e., normalize the data, fi lter the genes, build a model matrix for the comparison, estimate dispersions/coeffi cient of variation, run the negative binomial generalized linear model, test for signifi cance including multiple testing correction). For normalization, edgeR calculates TMM (trimmed mean of M -values) between each pair of samples that corrects for both sequencing depth variation between samples and possible undersampling of genes because of highly expressed genes in a sample. TMM calculates a set of scaling factors for the library sizes to minimize these two technical factors of RNAseq data. Count data was fi ltered to remove genes that had a TMM normalized count of <1 in >90% of the libraries. Th is resulted in 19,057 genes being included in the linear model fi t. Th en, a model matrix was built to perform the two-group comparison. Th e biological coeffi cient of variation was 29%. Finally, a negative binomial general linear model fi t was run for VDD yes vs. no, with adjustment for multiple comparisons using a false discovery rate <0.05.
Pathway and functional annotation analysis
Enrichment for Gene Ontology terms was performed using AmiGO 2 v.2.2.3 ( 42 ) . Pathway analysis was performed by searching the Reactome pathway database v.50 ( 43 ) . Gene-annotation enrichment analysis and functional annotation clustering was performed using DAVID v.6.7 ( 44 ) . 
Statistical analysis
RESULTS
Patient characteristics
One hundred and ninety subjects with biopsy-proven NAFLD were evaluated in the present study. VDD was present in 55% (105 subjects) of this cohort, with 26% and 19% classifi ed as vitamin D insuffi cient and suffi cient, respectively. Overall, the majority of subjects in this study cohort were non-Hispanic whites (77%), obese (71%), and female (53%). Patient characteristics including clinical, demographic, racial, and specifi c dietary/behavioral factors thought to eff ect vitamin D levels, such as dietary and supplemental vitamin D and calcium consumption, household income, weekly metabolic equivalent expenditure, and compiled average sunlight for each site during the month of sample collection are summarized in Table 1 . Th ere was a signifi cant positive trend for increased age with higher serum vitamin D levels. Th ere were signifi cant diff erences between groups for supplemental calcium consumption as well as for average sunlight at the time of serum collection. Th ere was a positive trend of increased dietary vitamin D consumption across groups, which failed to attain statistical signifi cance ( P =0.059). No other diff erences between groups were observed including for BMI, race, ethnicity or the presences of obesity, diabetes, or the metabolic syndrome.
Association of VDD and non-alcoholic steatohepatitis in NAFLD subjects
Th ere was a signifi cant diff erence in the proportion of subjects given the diagnoses of "not NASH/borderline NASH compared with defi nitive NASH" according to their serum vitamin D level category. Subjects with VDD were more likely to be diagnosed as "defi nitive NASH" (67%), compared with subjects in either 
Relationship of VDD and histologic severity of NAFLD
We analyzed the relationship of VDD and histologic features of NAFLD using stepwise ordinal and logistic regression aft er adjusting for covariates defi ned a priori , including age, sex, BMI, race, ALT, and diabetes status. Increased histologic severity of NAFLD, as evidenced by a higher NAS, was associated with VDD (OR=1.90, 95% CI, 1.13-3.23, P =0.016; Figure 1b ). In agreement with an association with NAS, VDD was also associated with more ballooning (OR=2.38, 95%CI, 1.32-4.30, P =0.004; Figure 1c ) and a higher lobular infl ammation grade (OR=1.98, 95% CI, 1.08-3.61, P =0.026; Figure 1d ). Last, VDD was associated with the presence of any fi brosis (OR=2.32, 95% CI, 1.13-4.77, P =0.022; Figure 1e ). VDD was not associated with grade of steatosis or other histologic features of NAFLD such as Mallory bodies, acidophils, or megamitochondria. Furthermore, we found that neither mean sunlight nor dietary vitamin D levels were associated with any of the histological features of NASH shown in Figure 1 . Th is suggests that the in vivo physiological state of VDD per se was associated with the observed worsened histological features of NASH rather than the main contributory factors of VDD alone.
Differences in laboratory tests between VD level category groups
Mean levels of routine clinical laboratory assessments and proinfl ammatory cytokines/adipokines IL-1β , IL-6, IL-8, tumor necrosis factor-α , resistin, and adiponectin are shown in Table 2 . Th ere was a signifi cant diff erence between the VD groups in the level of resistin and number of leukocytes, but no diff erences in aminotransferases or metabolic abnormalities including fasting insulin and glucose levels, homeostatic model assessment-IR, and plasma lipid levels.
Factors affecting serum vitamin D 25(OH)D3 levels
In this study, we collected data on several variables thought to infl uence serum vitamin D levels, as shown in Table 3  ( 2,3 ,26,32,46,47 ) . Linear regression analysis was performed to investigate the relationship of these factors to vitamin D 25(OH) D3 levels in this population. In univariate analysis, Hispanic ethnicity was associated with decreased serum vitamin D 25(OH) D3 levels ( β =−0.16, P =0.029). Increased BMI ( β =−0.14, P =0.052) and non-white race ( β =−0.14, P =0.054) were also associated with decreased serum vitamin D 25(OH)D3 levels, but failed to reach statistical signifi cance. Mean sunlight at the time of sample LIVER VOLUME 111 | JUNE 2016
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as a cutoff for incorporation into the model. Overall, Hispanic ethni city ( β =−0.18, P =0.038) and BMI ( β =−0.20, P =0.018) were inversely associated with serum vitamin D 25(OH)D3 levels, whereas mean sunlight at the time of sample collection ( β =0.27, P =0.002) was positively associated with serum vitamin D 25(OH) D3 levels.
collection ( β =0.31, P <0.001), increased age ( β =0.17, P =0.018), and dietary vitamin D consumption ( β =0.17, P =0.047) were associated with higher vitamin D 25(OH)D3 levels. To investigate the relationship between the combined eff ects of these factors on 25(OH)D3 levels, forward stepwise multivariable linear regression modeling was performed; a P value of <0.10 was used Bold values are signifi cant at P < 0.05.
LIVER
Vitamin D Deficiency and Non-Alcoholic Steatohepatitis
Hepatic transcriptomic profi ling of VDD subjects
To investigate if VDD is associated with changes in hepatic gene expression in NAFLD, we compared available hepatic transcriptomic profi ling data obtained by RNA sequencing in a subset of our cohort: 31 VDD subjects as compared with 38 subjects with vitamin D 25(OH)D3 levels ≥20 ng/ml. Four protein coding genes and the gene for the small nucleolar RNA, C/D box 3C ( SNORD3C ), were diff erentially expressed between these groups at a false discovery rate <0.05. As shown in Table 4 , the KRT10 (keratin 10), ARSD (arylsulfatase D), and SNORD3C genes were downregulated, whereas the SEMA3B (Sema domain, immunoglobulin (Ig) domain, short basic domain, Secreted), IGKV4-1 (immunoglobulin kappa variable 4-1) were upregulated in the VDD subjects. An additional four protein encoding genes and another small nucleolar RNA gene ( SNORD3D ) were diff erentially expressed between these groups at 0.05<false discovery rate<0.1. Th ese included the upregulated IGLV8-61 (Ig lambda variable 8-61), FOS (v-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog), and SLC51B (Solute Carrier Family 51, Beta Subunit) genes and the SNORD3D and TFF3 (Trefoil Factor 3) genes, which were downregulated. Th e potential relationship to NASH pathogenesis, shown in Table 4 , was identifi ed for each gene by screening the DAVID Bionformatics Database ( 44 ) and through a review of the literature. Higher-order functional analysis was investigated for the top 10 diff erentially expressed genes shown in Table 4 by searching for enrichment of gene ontology terms using AMIGO2 ( 43 ) ( Supplementary Table 13 ) and pathway analysis was performed by searching the Reactome pathway database ( 44 ) ( Supplementary Table 14 ) . Similar results were obtained in both analyses and included many immune-related gene ontology terms and Reactome pathways. Th e DAVID Bionformatics Database also identifi ed a cluster of annotations (Enrichment Score: 2.01) related to Ig-like domains, which identifi ed the IGLV8-6 , IGKV4-1 , and SEMA3B genes ( Supplementary Table 15 ).
DISCUSSION
In this study, we report an inverse association between worsened histologic features of NAFLD and vitamin D 25(OH)D3 levels aft er adjusting for potential confounding variables. VDD was also associated with a defi nitive diagnosis of NASH. Although a number of studies have investigated the association of VDD and NAFLD compared with non-disease controls using surrogate diagnostic measures such as liver enzyme levels or ultrasonography, relatively few studies have attempted to investigate whether VDD would be associated with biopsy-proven NASH and histologic disease severity in adults ( 2 ). Our fi ndings are in agreement with the majority of these studies ( 22, 25, 26 ) . Th e role of VDD in studies performed in children with biopsy-proven NAFLD have also shown confl icting results ( 23, 24, 27 or fasting glucose and insulin levels between the groups. We did however fi nd signifi cantly higher leukocyte counts in VDD subjects, which likely refl ects the overall induction of infl ammation in these subjects. Th e association of VDD with worsened NASH pathology including increased NAS and lobular infl ammation is in agreement with our recent study in a rat model of NAFLD and VDD ( 9 ) . Th e observed increased levels of serum resistin in this study is the fact that these studies were discrepant with regard to an association of VDD with histological severity. For example, both studies found that VDD subjects were signifi cantly younger than subjects with suffi cient or insuffi cient VD levels and that a lower proportion of Caucasians compared with non-Caucasians and a higher proportion of Hispanics compared with non-Hispanics were VDD compared with the other two categories. Moreover, neither study found diff erences in liver enzymes, plasma lipids, 
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Vitamin D Deficiency and Non-Alcoholic Steatohepatitis also consistent with the increase in hepatic resistin gene expression seen in our rat model. However, we did not see decreased serum adiponectin or an increase in other proinfl ammatory cytokines levels in our study. Resistin has been shown to be elevated in NAFLD subjects and is associated with increased IR and NF-κ B activation ( 48, 49 ) . Moreover, our novel hepatic transcriptome profi ling results implicate activation of the mitogen-activated protein kinase (MAPK) and NF-κ B infl ammatory pathways. Th is study clearly demonstrates the relationship between NAFLD activity/ severity and VDD based on liver biopsy results. However, as in previous reports, this relationship could not be found between serum markers of disease severity and VDD ( 2, 22, 25, 26 ) . It should also be noted that since VDD is also common in patients with noncholestatic chronic liver diseases, it cannot be ruled out that parenchymal damage may have a causative role in the development of VDD ( 50, 51 ) . Moreover, the lack of benefi cial eff ects of vitamin D supplementation in a number of diff erent disease treatment trials questions the etiological role of VDD ( 52, 53 ) . We also sought to investigate the potential factors that could contribute to VDD in this cohort. Using the "Comparative Climatic Data For the United States Th rough 2010" published by the National Climatic Data Center, we compiled sunlight data for each month at each of the eight NASH CRN clinical sites. As expected, we found that the mean hours of sunlight during the month of sample collection was an independent predictor of higher VD3 levels. We also found that a higher BMI and Hispanic ethnicity was inversely associated with VD3 levels. BMI has previously been associated with VDD, which may be due to sequestration of VD3 within adipose tissue, although this remains unclear ( 46 ) . It is likely that the association of lower VD3 levels and Hispanic ethnicity we observed is due to decreased formation of pre-VD3, from pro-VD3 due to absorption of UV radiation by melanin as a result of the darker skin pigmentation in these subjects ( 47 ) .
Recent studies have provided insight into new physiologic functions of VD3 (i.e., a protective anti-infl ammatory role), in addition to the classic action of VD3 in bone mineral metabolism, corresponding with the identifi cation of widespread tissue distribution of the vitamin D receptor ( 2 ) . Recent studies have shown that VD3 suppresses several pathways involved in infl ammation and cytokine production including MAPK and NF-κ B (54) (55) (56) . In cultured human adipocytes, VD3 protects against macrophage-induced activation of NF-κ B and MAPK signaling and subsequent release of several cytokines and chemokines, via upregulation of Iκ Bα expression and reduced NF-κ B p65 phosphorylation and downregulation of phosphorylated p38 MAPK and phosphorylated extracellular signal-regulated protein kinase 1/2, respectively ( 54 ) . In a similar study, Mutt et al. ( 55 ) have shown that VD3 inhibits Iκ B phosphorylation-mediated NF-κ B translocation into the nucleus in lipopolysaccharide-induced primary adipocytes and bone marrow-derived human mesenchymal stromal cells diff erentiated into adipocytes, resulting in decreased IL-6 secretion and transcription ( 55 ) . As increased accumulation of macrophages in adipose tissue is a hallmark of obesity and NAFLD, these studies provide a mechanistic link between VDD and the infl ammatory response, which is a key pathogenic event in NAFLD. In addition, dietary vitamin D supplementation decreased MAPK and NF-κ B activation in a murine model of colon cancer ( 56 ) .
Th e results of our hepatic transcriptome profi ling are in agreement with the above studies implicating upregulation of the MAPK and NF-κ B infl ammatory pathways in our VDD NAFLD subjects. For example, Reactome pathway analysis revealed several common Reactome pathways for 5 of the top 12 DE genes, which includes four immunoglobulin genes (i.e., IGKV4-1 , IGLV8-61 , IGHG1 , IGKC ) and the transcription factor FOS . Th e common Reactome pathways for these genes include Fc epsilon ment in contrast to subjects without this variant. Th ese authors also showed that NAFLD subjects with the VDR A1012G GG genotype had lower VDR expression compared with the other genotypes for this SNP, suggesting this SNP may contribute to VDD-mediated pathogenesis in NAFLD ( 61 ) . Several other diff erentially expressed genes in our study also point to involvement of the MAPK and NF-κ B pathways in VDD NAFLD patients. Th e keratin 10 gene, KT10 , which was decreased fi vefold, was the most signifi cant DE gene in VDD subjects. Previous studies have shown that VD3 upregulates KT10 expression ( 62 ) , and that MAPK is activated in KT10 (−/−) knockout mice ( 63 ) . Moreover, KT10 expression in the basal epidermis in transgenic mice leads to impaired NF-κ B activity via inhibition of Akt in these cells ( 64 ) . Together, these studies suggest that VDD-mediated decreased expression of KT10 leads to MAPK activation and potential enhanced Akt and NF-κ B activity. In contrast, semaphorin 3B (gene SEMA3B ; increased >3-fold in VDD subjects) was associated with decreased Akt phosphorylation via binding neuropilin-1, but also subsequent increased apoptosis ( 65 ), which we have recently shown to be associated with NASH ( 66 ) . SEMA3B expression also leads to neuropilin-1-mediated MAPK activation, and subsequent release of the chemokine IL-8 in vitro ( 67 ) . Although we did not observe increased serum IL-8 levels in our VDD subjects, in a related hepatic transcriptomic study, we found IL8 to be one of the most signifi cantly upregulated genes in patients with NASH compared with subjects with steatosis alone (unpublished observations).
receptor (Fcε RI) signaling, Fcε RI-mediated MAPK activation, Fcε RI-mediated NF-κ B activation, classical antibody-mediated complement activation, Fcγ R activation, creation of C4 and C2 activators, and initial triggering of complement. Fcε RI is the high-affi nity IgE receptor, which is present on mast cells, and other antigen-presenting cells including macrophages and dendritic cells. Binding of IgE to Fcε RI induces a number infl ammatory autocrine and paracrine eff ects including activation of the MAPK, NF-κ B, tumor growth factor-β (TGF-β ) and TLR signaling pathways resulting in the production of cytokines and chemokines such as tumor necrosis factor-α , IL-1, IL-8, Monocyte chemoattractant protein-1, and other infl ammatory mediators, thus facilitating amplifi cation of both innate and acquired immune responses ( 57, 58 ) . Binding of IgE to Fcε RI also strongly activates the transcription factor FOS ( 57, 58 ) . FOS is then phosphorylated and stabilized by extracellular signal-regulated protein kinase through the activation of the MAPK pathway ( 59 ) . Together with JUN, FOS dimerizes to form the transcription factor AP-1, which is a major regulator of infl ammation, apoptosis, diff erentiation, and transformation ( 59 ) . AP-1 synergizes with SMAD3 and SMAD4 at TRE binding sites to activate genes in response to induction of TGF-β signaling ( 60 ) . Interestingly, a recent study showed that VD3 ameliorated TGF-β -induced fi brogenesis in primary hepatic stellate cells and that this response was, in part, dependent on certain SNPs in the VDR gene ( 61 ) . For example, stellate cells with the VDR A1012G GG genotype (rs4516035) had no reduction in TGF-β following VD3 treat- 
Vitamin D Deficiency and Non-Alcoholic Steatohepatitis
We recognize limitations to the current study, including more sensitive measures of abdominal fat distribution and insulin sensitivity and the relatively small number of subjects with hepatic transcriptome data, which likely reduced the number of genes that were signifi cantly diff erentially expressed between NAFLD subjects with VDD and those with suffi cient VD levels. Th e lack of an association between circulating biomarkers (e.g., cytokines) and VDD status may be because of the timing of biospecimen collection in relation to VDD. In addition, the pleiotropic role of cytokines in diverse biological processes, most of which use the circulatory system as the mode of transportation, can make the identifi cation of specifi c biological relationships (e.g., cytokines and VDD status) diffi cult to discern from a single peripheral measure. As usual in association studies of this type we cannot prove causality; whether these observations represent a novel mechanism linking VDD to infl ammation, parenchymal damage, and NASH severity will need to be confi rmed by detailed mechanistic studies.
In summary, we have found that VDD in our NAFLD subjects was associated with a defi nitive diagnosis of NASH, increased lobular infl ammation, more ballooning, and the presence of fi brosis. Taken together, the results of hepatic transcriptomic profi ling in VDD subjects compared with subjects with VD3 ≥20 ng/ml suggest that the MAPK, NF-κ B, TGF-β , and Akt pathways may be involved in the increased histologic severity seen in our VDD NAFLD subjects. Th ese data are in agreement with a recent study by our group in a rat model of NAFLD and VDD, which also showed that VDD was associated with increased disease severity and upregulation of hepatic infl ammatory and TLR genes ( 9 ) .
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